EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment

Epidermal growth factor receptor (EGFR) and the mutant EGFRvIII are major focal points in current concepts of targeted cancer therapy for glioblastoma multiforme (GBM), the most malignant primary brain tumor. The receptors participate in the key processes of tumor cell invasion and tumor-related ang...

Descripción completa

Detalles Bibliográficos
Autores principales: Keller, Stefanie, Schmidt, Mirko H. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486116/
https://www.ncbi.nlm.nih.gov/pubmed/28629170
http://dx.doi.org/10.3390/ijms18061295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486116/
https://www.ncbi.nlm.nih.gov/pubmed/28629170
http://dx.doi.org/10.3390/ijms18061295

Ejemplares similares